figitumumab

DRUG3 trials

Sponsors

Pfizer

Conditions

Breast CancerBreast NeoplasmsColorectal NeoplasmsLung NeoplasmsProstatic NeoplasmsSarcomaSmall Cell Lung Carcinoma

Phase 1

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

WithdrawnNCT00635245

PfizerBreast Cancer

Updated: 2015-03-11

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

TerminatedNCT00976508

PfizerBreast Neoplasms, Colorectal Neoplasms, Lung Neoplasms +2

Start: 2009-11-30End: 2012-10-31Updated: 2013-12-13

Phase 2

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

TerminatedNCT00977561

PfizerSmall Cell Lung Carcinoma

Start: 2010-04-30End: 2011-10-31Updated: 2013-02-25

Related Papers

Case Report: Should IGF-1R targeted therapy be revisited in Ewing sarcoma? a report of long-term complete response and review of the literature.

2025-11-19